Brand Name Pharmaceutical Manufacturing in Ohio
Over the five years to 2018, revenue for the Brand Name Pharmaceutical Manufacturing industry in Ohio is forecast to rise. During the five-year period, primary factors driving industry growth include an increase in the number of leading global pharmaceutical companies leasing or operating facilities in the state and rising private investment, including funding from nationally accredited institutes such as the National Institutes of Health. Furthermore, the state's thriving biotechnology community supported the industry's research and development efforts. Over the five years to 2023, revenue growth is expected to be fueled by an influx of new entrants to the state's bioscience community. As the state becomes an attractive hub for pharmaceutical manufacturing, the number of enterprises is expected to grow.
Pharmaceutical manufacturers develop prescription and over-the-counter products that are used to prevent or treat illnesses in humans or animals. Brand name drugs and medication have patent protection. This industry does not include nutritional supplement or cosmetic product manufacturers.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.